1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one

We are 1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one CAS:94576-68-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one
Other Name: α-Morpholino-p-phenyl-isobutyrophenon;1-biphenyl-4-yl-2-methyl-2-morpholin-4-yl-propan-1-one
CAS No: 94576-68-8
MF: C20H23NO2
MW: 309.40200
Melting point: 122.1-122.7℃
UN Number: N.A
UN Proper Shipping Name: N.A
Transport hazard class: N.A
Packing group: N.A
 
Specification
Appearance: White to yellow powdery solid
Assay: ≥99%
 
Application
It can replace the traditional type 907 photoinitiator, which is the only cost-effective alternative to 907 due to its biological toxicity in 2011.
Product advantages:
1.The molecular structure does not contain sulfur, so there is no 907-specific unpleasant residual "Chinese medicine flavor" after light curing.
2.Remarkably resistant to yellowing than 907, can be used in varnish systems when used alone.
3.It can be used in high-end UV applications where the VOC release is strictly controlled.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one


Related News: This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.cytidine CAS:65-46-3 The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.71-91-0 The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.5-Bromo-2-fluoropyridine CAS:766-11-0 The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.

Related Products
Product Name
3-Bromo-4-fluorobenzonitrile View Details
1-Fluoro-2-nitrobenzene View Details
Tyramine hydrochloride View Details
4′-Hydroxy-3′-methylacetophenone manufacturer 4-ethenyl-2,3-dihydro-1-benzofuran manufacturer (2R,3S)-3-Phenylisoserine manufacturer 4-fluoro-2-nitro-1-(trifluoromethyl)benzene manufacturer 4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihyd ro-3-pyridinecarboxylic acid manufacturer